Continued positive momentum in givastomig Phase 1b combination trial in first-line gastric cancer, with topline dose escalation data (n=17) ...

Lindsi Franklin’s son, Isaac, was 9 years old in June 2024 when doctors found an abscess in his stomach and a section of ...

Remaining $60 Million of outstanding convertible notes to be repurchased post-close of pending UDENYCA divestiture – REDWOOD CITY, Calif., ...

A new report from the American Cancer Society has revealed the latest risk factors and trends of cancer rates and predictions ...

Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel achieved a 17.1% overall response rate (ORR), including one complete response, compared to 5.3% ORR for paclitaxel alone, ...

Dragon fruit is a tropical superfood packed with vitamins, antioxidants, and fiber. Among many benefits, it can boost ...

Every culture has its own special soup. The belief is that a bowl will make you feel better if you're feeling under the ...

When it comes to performance-enhancing substances, pickle juice might not be the first thing that comes to mind. But athletes ...

The Trump administration is going full steam ahead on its terrifying project of dismantling the country’s defenses against ...

Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with more than one million new diagnoses annually.

Researchers conducted a meta-analysis of studies to explore the efficacy and safety of pembrolizumab alone and in combination with chemotherapy for the treatment of gastric and GEJ cancers.